Related Experiment Video
Updated: May 28, 2026

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
Classic in vivo cancer models: three examples of mouse models used in experimental therapeutics
Anna Kruczynski1, Bridget T Hill
1Centre de Recherche Pierre Fabre, Cedex, France.
Abstract:
Transplantable animal tumors have been associated with the discovery of most clinically active anticancer agents. They are still useful today in conducting detailed evaluations of new candidate anticancer drugs. Three protocols relating to transplantable experimental tumors are described in this unit. Included are the intravenously-implanted murine P388 leukemia, the subcutaneously-implanted murine B16 melanoma and two examples of subcutaneously-implanted human tumor xenografts, the LX-1 (lung) and MX-1 (breast) tumors.
Insights
Transplantable animal tumors, including murine leukemia and melanoma, are crucial for evaluating new anticancer drugs. This study details protocols for using these models, alongside human tumor xenografts, in preclinical cancer research.
Area of Science:
- Oncology
- Pharmacology
- Preclinical Cancer Research
Background:
- Transplantable animal tumor models have historically driven the discovery of anticancer drugs.
- These models remain vital for the rigorous evaluation of novel therapeutic agents.
- Standardized protocols are essential for reproducible preclinical drug testing.
Purpose of the Study:
- To describe established protocols for utilizing transplantable experimental tumors in drug evaluation.
- To present methodologies for in vivo assessment of anticancer agent efficacy.
- To highlight the utility of murine and human xenograft models in oncology research.
Main Methods:
- Detailed protocols for intravenously-implanted murine P388 leukemia.
- Methodologies for subcutaneously-implanted murine B16 melanoma.
- Procedures for subcutaneously-implanted human tumor xenografts (LX-1 lung, MX-1 breast).
Main Results:
- Established protocols enable consistent use of P388 leukemia, B16 melanoma, LX-1, and MX-1 models.
- These models facilitate detailed pharmacokinetic and pharmacodynamic studies of anticancer agents.
- The described methods support comparative efficacy assessments of novel drug candidates.
Conclusions:
- The described protocols provide a foundation for robust preclinical anticancer drug evaluation.
- Transplantable tumor models are indispensable tools in the development pipeline for new cancer therapies.
- Utilizing both murine and human xenograft models offers comprehensive preclinical insights.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

